Minerva Neurosciences, Inc.
NERV
$5.21
-$0.29-5.27%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -51.60% | -- | -66.38% | -67.31% | 152.05% |
| Gross Profit | 51.60% | -- | 66.38% | 67.31% | -152.05% |
| SG&A Expenses | 10.58% | -22.58% | -14.11% | 1.02% | 3.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.16% | -34.86% | -46.25% | -41.59% | -36.95% |
| Operating Income | -10.16% | 34.86% | 46.25% | 41.59% | 36.95% |
| Income Before Tax | -6,540.16% | -112.19% | 60.42% | 56.20% | 52.65% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6,540.16% | -112.19% | 60.42% | 56.20% | 52.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6,540.16% | -112.19% | 60.42% | 56.20% | 52.65% |
| EBIT | -10.16% | 34.86% | 46.25% | 41.59% | 36.95% |
| EBITDA | -10.16% | 34.87% | 46.26% | 41.60% | 36.95% |
| EPS Basic | -4,420.61% | -112.19% | 60.42% | 56.21% | 52.65% |
| Normalized Basic EPS | -4,419.95% | -112.19% | 60.42% | 56.20% | 52.64% |
| EPS Diluted | -4,420.61% | -112.21% | 60.42% | 56.21% | 52.69% |
| Normalized Diluted EPS | -4,419.95% | -112.19% | 60.42% | 56.20% | 52.64% |
| Average Basic Shares Outstanding | 46.89% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 46.89% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |